Red Violet: The Gap Between Its 23% Growth and Its 85% Profit Jump Is the Real Story

Red Violet (RDVT) filed a set of record second-quarter numbers in early August, and the headline was the top line: revenue up 23% year over year to $26.7 million. But that is not the part worth your attention. In the same quarter, net income jumped 85% to $5.0 million, adjusted EBITDA rose 48% to $11.2 million, and cash flow from operations climbed 42% to $10.6 million. Profit grew two to three times faster than revenue. For a small-cap identity-intelligence company trading around $1.2 billion in market value, that gap between growth and earnings is the actual story — and the question it raises for the valuation is the one that will decide whether this name belongs in your portfolio.

Why profit outruns the revenue

The mechanism is operating leverage, and it matters more than the growth rate itself. Red Violet sells cloud-based identity and risk-intelligence software to businesses — verifying people, businesses, and assets for banks, insurers, collectors, screening firms, and law enforcement. Its two flagship products are CORE's IDI, a subscription data-intelligence platform, and FOREWARN, a realtor-focused identity service. That subscription model means the expensive part — the identity graph, the entity-resolution engine, the data plumbing — is largely built and paid for in advance. Each new customer adds revenue at a very high incremental margin, because the hard cost base barely moves.

The numbers show the shape of it. Adjusted gross margin ran at 86%, up from 84% a year ago, and adjusted EBITDA margin expanded to 42% from 35%. Net margin more than tripled the growth rate, reaching 19% from 12%. This is what it looks like when revenue growth is real but converting into proportionally larger profit: the platform's cost is mostly fixed, so the last dollar of subscription revenue falls through to the bottom line at an 80%-plus gross margin.

That is a high-quality profitability profile, not an accident of the quarter. In the second quarter the company signed a record 447 new IDI customers, bringing its total billable base to 10,869, and management said four of five verticals posted record revenue. For the full year 2025, revenue hit $90.3 million (up 20%) with GAAP earnings per share of $0.91. And the balance sheet is clean: no debt, $50 million of cash, and operating cash flow that keeps compounding.

The factor read

Put through the five-factor screen, this is the rare report card where profitability, growth, and safety all sit in the top tier at once, with momentum confirming rather than contradicting.

• Profitability: A. Adjusted gross margin of 86% and a 42% adjusted EBITDA margin are exceptional for any software company, let alone one growing at a 23% clip.
• Growth: A. Revenue accelerated from 14% in the year-ago quarter to 23% now, and the customer-add record shows the acceleration is broad-based rather than one big contract. The one crack: the IDI real-estate vertical slipped modestly on housing headwinds, and management is leaning on newer verticals like home healthcare and investigative services to make up the difference.
• Safety: A. No debt, $50 million of cash, $10.6 million of quarterly operating cash flow — a small cap with a fortress balance sheet. The net-income jump is real cash, not accounting.
• Momentum: B. The stock sits about 9% above its 50-day average and roughly 42% above its 200-day, with a 14-day RSI near 58. The trend is up and the tape is not yet screaming overbought.

Then comes the fifth factor, and it is where this story gets honest.

Valuation has already noticed

The valuation factor is the weak spot, and I will say that plainly rather than paper over it: the market has already priced in much of this good news. At roughly $1.2 billion in market value against an annualized revenue run rate around $105 million, Red Violet trades at something like 11 times sales — a premium multiple that assumes the growth and margins continue. The earnings multiple is richer still. The honest caveat is that this is a tiny company with few clean public comparables — the big credit bureaus it squints against are vastly larger and differently structured — so there is no tidy sector median to lean on. In our book, that premium is the cost of entry, not current evidence, and it makes the "cheap" question unanswerable rather than answered.

The second wrinkle cuts the other way on shareholders. In August the company completed an underwritten public offering of 1,916,667 shares that raised about $109 million in net proceeds, earmarked for working capital, general corporate purposes, and potential acquisitions. That is roughly a 14% dilution to the prior share count. The cash cushions an already debt-free balance sheet, and management calls it the strongest strategic position in company history — but shareholders just absorbed a dilutive raise on top of a premium valuation. One small offset: the company still had about $15.5 million left under its buyback program at the end of June, having repurchased 74,500 shares year-to-date at an average price of $41.87. The buyback is small against the raise, but it signals management is not uniformly eager to print shares.

What the factor stack says to do

So the reading flips the way a good factor report should. Narrative says "record growth." The data confirms the business economics are genuinely excellent — this is a debt-free, 86%-adjusted-gross-margin compounder with momentum behind it, the sort of GARP profile that earns a place in a growth sleeve. But the price already embodies that quality. A stock this strong should not be cut mechanically just because it ran; letting winners run is part of the process. The discipline here is about new money, not existing holdings.

For a fresh buyer, the report card says the business is durable and the entry point is demanding: a premium sales multiple, a high earnings multiple, and a recent 14% dilution. That is the definition of needing more structure, not more conviction. Holders already benefiting from the run have the quality to justify staying through valuation on a leader — but never letting the "it's a great company" narrative override the process. The trigger that changes the picture either way is the same one: whether revenue keeps compounding at 20% plus while margins hold. If that stops, the premium multiple has nowhere to hide. If it continues, the market has found the next year of the story. Nothing in the second-quarter print settles that — it just made the bet more expensive to place.